This treatment is suitable for individuals struggling with obesity or looking to shed unwanted pounds for health or aesthetic reasons
Overweight or obese people can become leptin-resistant, meaning the brain does not respond as sensitively to leptin
Advertising a drugs name and a use that is off-label is a double whammy, said Patrick Massad, commissioner of the Pharmaceutical Advertising Advisory Board (PAAB), an organization that is independent from Health Canada and that reviews drug advertising to ensure compliance
In patients with IIH, abrupt cessation of GLP-1RA therapy has been reported to lead to a return of symptoms or new onset IIH in two separate case reports, highlighting the requirement of continuous therapy (22,24)
Pode contribuir para maior disposio e rendimento fsico
doi: 10.3389/FIMMU.2018.02939/BIBTEX 180 ValentaRHochwallnerHLinhartBPahrS